Year founded
-
Country of origin
Kenya
HQ country
Kenya
Total deal value
Average deal value
Company industry
- Healthcare & Pharmaceuticals
M&A expertise
- -
Industry expertise
- -
Maxim Pharmaceuticals, Inc. founded in 1954, is a biopharmaceutical company, develops cancer therapeutics. Its lead drug candidate, Ceplene, is in a phase III clinical trial as a remission maintenance therapy for patients with acute myeloid leukemia, a form of adult leukemia. As of January 4, 2006, Maxim Pharmaceuticals Inc. was acquired by EpiCept Corporation.